![Robert Letellier](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Letellier active positions
Companies | Position | Start | End |
---|---|---|---|
AB Biotech, Inc.
![]() AB Biotech, Inc. Pharmaceuticals: MajorHealth Technology AB Biotech, Inc. develops and commercializes immunological products. It also develops an immunological approach to sexing semen for all species and humans. The company was founded by Robert Letellier in 2004 and is headquartered in Montréal, Canada. | Director/Board Member | 30/09/2004 | - |
Chief Executive Officer | 20/10/2010 | - | |
Founder | 20/10/2010 | - | |
President | 20/10/2010 | - |
Career history of Robert Letellier
Former positions of Robert Letellier
Companies | Position | Start | End |
---|---|---|---|
PharmaGap, Inc.
![]() PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada. | Director/Board Member | 10/11/2009 | - |
Founder | 10/11/2009 | - | |
Independent Dir/Board Member | 05/10/1999 | - |
Training of Robert Letellier
University of Sherbrooke | Undergraduate Degree |
Statistics
International
Canada | 4 |
Operational
Director/Board Member | 2 |
Founder | 2 |
Independent Dir/Board Member | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
PharmaGap, Inc.
![]() PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada. | Health Technology |
AB Biotech, Inc.
![]() AB Biotech, Inc. Pharmaceuticals: MajorHealth Technology AB Biotech, Inc. develops and commercializes immunological products. It also develops an immunological approach to sexing semen for all species and humans. The company was founded by Robert Letellier in 2004 and is headquartered in Montréal, Canada. | Health Technology |
- Stock Market
- Insiders
- Robert Letellier
- Experience